This is a chart analysis using the same data from the previous COVID-19 paper1 to focus specifically on the state of Florida and further focus on selected metropolitan areas.
A new study by University of Florida researchers aims to identify a drug or drugs that can potentially be used to prevent and/or treat infection with COVID-19.
University of Florida Health has enrolled its first patient in a clinical trial for the Regeneron Pharmaceuticals’ monoclonal antibody cocktail to treat COVID-19.
Researchers and clinicians continue to search for ways to alleviate the suffering of patients and the demands on crowded hospitals.
It’s a term we’re going to hear much more frequently during the final chapter of the COVID-19 pandemic — herd immunity.
Families are beginning to ask more questions about when COVID-19 vaccines will be offered to children younger than 16, and...
Efforts are in underway to speed up the process on COVID-19 research for UF Health researchers to evaluate a drug treatment for coronavirus.
The University of Florida College of Medicine’s department of pediatrics has been awarded a nearly $1 million federal grant to expand telemedicine services and equipment among underserved and vulnerable populations.
Choices are affected by how people see the world, whom they trust, their perceptions of risk and consistency of message.
Lisa Merlo Greene, director of wellness programs at the University of Florida College of Medicine, offers tools to maintain wellness during a time of uncertainty.
Cindy Prins, Ph.D., offers infection control assessments for UF entities who aim to resume activities throughout campus.
A team of University of Florida neuroscientists will analyze two different smell tests under a new National Institutes of Health grant...